- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05299320
Postural Control in Covid-19
July 22, 2022 updated by: Hikmet Kocaman, Karamanoğlu Mehmetbey University
Covid 19 and Postural Sway: A Comprasion of SARS-CoV-2 and Healthy Sedentary Women
This study was planned to investigate how much the anaerobic performance of individuals who experienced fatigue with Want (Wingate) affected their postural sway parameters.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The postural sway parameters of the individuals will be evaluated using the "Kistler Force Plate" and the anaerobic values will be evaluated using the Wingate Anaerobic Strength Test and the "Excalibur Sport Ergometer" device.
The data obtained will be compared with the data of patients with and without Covid-19 disease using appropriate statistical methods.
Study Type
Observational
Enrollment (Actual)
56
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karaman, Turkey
- Karamanoglu Mehmetbey University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patients with covid-19 and Have not had covid 19 before
Description
Inclusion Criteria:
- Being between the ages of 18-30, - Being a volunteer - Having had Covid 19 in the last 3 month
Exclusion Criteria:
- Presence of neurologic and oncologic disease - Presence of orthopedic surgery - Presence of active Covid 19 disease - Any cardiopulmonary disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with Post-Covid
Being between the ages of 18-30, - Being a volunteer - Having had Covid-19 in the last 3 month Exclusion Criteria - Presence of neurologic and oncologic disease - Presence of orthopedic surgery - Presence of active Covid-19 disease - Any cardiopulmonary disease
|
Neuromuscular fatigue will be established by using the Excalibur Sport Ergometer device and the Wingate Anaerobic Strength Test.
Postural sway will be evaluated with Cyst Force Plate Balance device.
This device is a precision device that provides objective measurable data.
Other Names:
|
|
Healthy Person
Being between the ages of 18-30, Being a volunteer, not having Covid-19 before
|
Neuromuscular fatigue will be established by using the Excalibur Sport Ergometer device and the Wingate Anaerobic Strength Test.
Postural sway will be evaluated with Cyst Force Plate Balance device.
This device is a precision device that provides objective measurable data.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postural Sway
Time Frame: 3 months
|
Postural sway will be evaluated with Cyst Force Plate Balance device.
This device is a precision device that provides objectively measurable data.
Thanks to its movable platform, it can measure in all directions.
Participants will be asked to stand on the platform assessing their body oscillations.
They will be asked to look at a still picture on the wall with their arms at the iliac and eyes directly opposite them.
Individuals will be asked to keep their designated positions for 30 seconds.
At the end of the specified period, the data obtained from the device will be saved.
Before and after the neuromuscular fatigue test postural sway will be evaluated.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ayşenur Gökşen, PhD, Tarsus Universty
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2022
Primary Completion (Actual)
June 10, 2022
Study Completion (Actual)
June 20, 2022
Study Registration Dates
First Submitted
March 25, 2022
First Submitted That Met QC Criteria
March 28, 2022
First Posted (Actual)
March 29, 2022
Study Record Updates
Last Update Posted (Actual)
July 26, 2022
Last Update Submitted That Met QC Criteria
July 22, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-2022/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on Neuromuscular fatigue and postural sway evaluation
-
sevilay seda basCompletedPes PlanusTurkey (Türkiye)
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedSclerosis, MultipleFrance
-
Istituti Clinici Scientifici Maugeri SpACompletedDiabetes Mellitus, Type 2 | Heart Failure Preserved Ejection FractionItaly
-
Institut de cancérologie Strasbourg EuropeUR 3072 - Mitochondrie, Stress oxydant et Protection musculaireCompleted
-
Centre Paul StraussRecruiting
-
Institut de cancérologie Strasbourg EuropeCompleted
-
Central Hospital, Nancy, FranceCompletedMobility | Attention Deficit | Postural ActivityFrance
-
Istanbul University - Cerrahpasa (IUC)RecruitingPediatric-onset Multiple SclerosisTurkey
-
Cairo UniversityNot yet recruiting
-
University Hospital, GrenobleUniversity Hospital, Montpellier; University Hospital, Caen; National Research... and other collaboratorsUnknownStroke | Swallowing DisordersFrance